Breadcrumb

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

IDIGH Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Lashanda Skerritt awarded Vanier Canada Graduate Scholarship

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...

Inappropriate prescriptions sending hospitalized seniors back to the ER

Improving hospital prescribing practices may reduce risk of rehospitalization and death

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

A good showing for the IDIGH Program in 2020-2021 FRQS awards

Congratulations to researchers and trainees!

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Explore news and events at the RI-MUHC